SLC2A1 and colorectal cancer: Overall, these data indicate that the DNA methylation-associated silencing of DERL3 in HCT-116 colorectal cancer cells causes a pro-tumorigenic upregulation of the SLC2A1 protein that can be reversed by restoring DERL3 activity.